- Risk Factors of the Development of Interstitial Lung Diseases in Children with Trisomy 21
Risk Factors of the Development of Interstitial Lung Diseases in Children with Trisomy 21
SOVREMENNAYA PEDIATRIYA.2017.4(84):62-65; doi 10.15574/SP.2017.84.62
Gonchar' M.O., Logvinova O. L., Muratov G. R., Yablons'ka N. M., Pomazunovs'ka O. P., Tsura O. M.
Kharkiv National Medical University, Ukraine
Communal Healthcare Institution Kharkiv Regional Children's Clinical Hospital, Ukraine
Objective: to improve the diagnosis of children's interstitial lung disease (chILD) in patients with trisomy 21 by determination and clustering the risk factors of a disease.
Material and methods. The 37 children with a trisomy of 21, among them 14 (37.8%) with chILD (the main group) and 23 (62.1%) without chILD (the comparison group), were observed. An average age of patients of the main group was 9.7±2.4 months, and in the comparison group — 11.2±3.6 months (r>0.05). Examination of children was conducted during the period from 2007 till 2016 at the Department of pediatrics No. 1 and the Department of neonatology of the Kharkiv National Medical University based on Kharkiv Regional Children's Hospital.
Results. When analyzing the maternal obstetric history of the main group related to respiratory disease, the latter made up 6.7±1.7%. In the ІІ trimester of pregnancy the acute respiratory disease was observed in 85.7% of the main group mothers that indicated statistically significant increased incidence (r<0.05).
The influence of an acute respiratory disease in the ІІ trimester of pregnancy on the formation of chILD was proved (DI 0.37–0.79; F (1.247)=3.93; p=0.049). The 2nd trimester of pregnancy is a the period of the formation of channels in a pulmonary mesenchyme, and completion of terminal bronchioles and acinuses development.
Conclusions. The key aspects regarding the chILD formation in children with trisomy 21 were complex heart defects or other congenital heart defects with increased pulmonary blood flow, using of the artificial blood-circulation bypass and long-term artificial lung ventilation (>7 days) during cardiovascular operation. The burdened perinatal history (acute respiratory infection in the ІІ trimester of pregnancy, congenital pneumonia in neonate) and cytomegalovirus infection in child's medical history had less clustered implication in formation of chILD in children with trisomy 21.
Key words: interstitial lung disease, risk factors, children, trisomy of 21 chromosomes.
1. Clement A, Nathan N, Epaud R et al. (2010). Interstitial lung diseases in children. Orphanet J Rare Dis. 5: 22. https://doi.org/10.1186/1750-1172-5-22; PMid:20727133 PMCid:PMC2939531
2. Clement A. (2004). ERS Task Force. Task Force on Chronic Interstitial Lung Disease in Immunocompetent Children. Eur Respir J. 24: 686—697. https://doi.org/10.1183/09031936.04.00089803; PMid:15459150
3. Deutsch GH, Young LR, Deterding RR et al. (2007). Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med. 176: 1120—1128. https://doi.org/10.1164/rccm.200703-393OC; PMid:17885266 PMCid:PMC2176101
4. Dinwiddie R, Sharief N, Crawford O. (2002). Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol. 34: 23—29. https://doi.org/10.1002/ppul.10125; PMid:12112793
5. Griese M, Haug M, Brasch F et al. (2009). Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany. Orphanet J Rare Dis. 4: 26. https://doi.org/10.1186/1750-1172-4-26; PMid:20003372 PMCid:PMC2800105
6. Hime NJ, Zurynski Y, Fitzgerald D et al. (2015). Childhood interstitial lung disease: A systematic review. Pediatr Pulmonol. 50: 1383—1392. https://doi.org/10.1002/ppul.23183; PMid:25931270
7. Kornum JB, Christensen S, Grijota M et al. (2008). The incidence of interstitial lung disease 1995—2005: a Danish nationwide population-based study. BMC Pulm Med. 8: 24. https://doi.org/10.1186/1471-2466-8-24; PMid:18983653 PMCid:PMC2642752
8. Kurland G, Deterding RR, Hagood JS et al. (2013). Classification, Evaluation, and Management of Childhood Interstitial Lung Disease in Infancy. Am J Respir Crit Care Med. 188: 376—394. https://doi.org/10.1164/rccm.201305-0923ST; PMid:23905526 PMCid:PMC3778735
9. Nathan N, Taam RA, Epaud R et al. (2012). A national internetlinked based database for pediatric interstitial lung diseases: the French network. Orphanet journal of rare diseases. 7: 40. https://doi.org/10.1186/1750-1172-7-40; PMid:22704798 PMCid:PMC3458912